Stem Cell-Derived Exosomes for Inflammatory Brain Disease Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current stem cell therapies for inflammatory brain diseases face limitations, including ethical concerns, limited therapeutic effects, and potential side effects such as tumor formation and brain damage, while existing treatments like antibiotics can cause serious brain damage and other complications.
Innovation Solution
A pharmaceutical composition using stem cell-derived exosomes from adult stem cells treated with thrombin, which are administered to inhibit cell death and reduce inflammatory cytokine levels in nerve cells, thereby treating inflammatory brain diseases effectively.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If stem cells are used for therapy, then therapeutic effects are improved, but tumor formation and brain damage risks increase
Solution Approach 1:
The invention extracts the therapeutic components (exosomes) from stem cells and uses them separately for therapy. This separation allows the therapeutic benefits to be retained while eliminating the harmful effects associated with whole stem cell transplantation, such as tumor formation and brain damage from large cell sizes.
Solution Approach 2:
The invention uses exosomes as a copy or carrier of the therapeutic information and functional molecules from stem cells. These exosomes replicate the beneficial effects of stem cells without requiring the actual stem cells to be present, thereby avoiding the risks associated with live cell transplantation.
2Adaptability or versatility
If adult stem cells are used, then ethical issues are avoided, but therapeutic effects are limited
Solution Approach 1:
The invention changes the parameter of stem cell treatment by using exosomes derived from adult stem cells treated with thrombin. This parameter change (from whole cells to exosomes, and addition of thrombin treatment) enhances the therapeutic effect while maintaining the ethical advantages of using adult stem cells.
Solution Approach 2:
The invention creates a composite therapeutic approach by combining exosomes from adult stem cells with thrombin treatment. This composite material (thrombin-treated exosomes) provides enhanced therapeutic effects compared to untreated exosomes or whole stem cells alone.
3Ease of operation
If stem cells are injected directly, then treatment is simple, but artery occlusion and brain damage occur
Solution Approach 1:
The invention extracts the harmful aspect (large cell size causing artery occlusion) by removing the whole stem cell and retaining only the exosomal component. This extraction maintains treatment simplicity while eliminating the mechanical obstruction caused by large cell sizes.
Solution Approach 2:
The invention uses exosomes as temporary, disposable therapeutic carriers that perform their function and are naturally cleared. These short-living exosomes provide the necessary therapeutic effect without persisting in the body like whole stem cells, thereby reducing long-term risks of artery occlusion and brain damage.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention relates to a composition for treating inflammatory brain diseases, which includes stem cell-derived exosomes as an active ingredient. The stem cell-derived exosomes according to the present invention can be usefully applied to the treatment of inflammatory brain diseases, because the exosomes have outstanding therapeutic effects, including inhibiting cell death due to inflammation in nerve cells, increasing the survival rate in an inflammatory-brain-disease animal model, and substantially reducing brain damage and inflammatory cytokine levels due to inflammatory reactions such as edema.